https://www.inspiredhygiene.com/feed&follow=1
-
Opinion: To make public health officials more accountable, they should be elected, not appointed
In the United States, the Covid-19 pandemic has resulted in the widespread firing and resignation of public health officers. According to one...
-
STAT+: Jennifer Doudna and Marty Chavez on where CRISPR meets Wall Street
You might know Jennifer Doudna as the Nobel Prize-winning pioneer of CRISPR genome editing, the subject of Walter Isaacson’s last book, or...
-
STAT+: As states push their own privacy laws, health tech companies fear compliance nightmare
Health tech companies worried that an emerging patchwork of state privacy laws will drive up regulatory costs are joining privacy hardliners in...
-
STAT+: FTC votes against probing the controversial practices of pharmacy benefit managers
In a closely watched meeting, the U.S. Federal Trade Commission voted against proceeding with a study to examine pharmacy benefit managers and how...
-
Agios wins FDA approval for drug to treat rare form of anemia
The Food and Drug Administration on Thursday approved a new drug from Agios Pharmaceuticals to treat people with a rare form of anemia. The...
-
Opinion: Welcome back to the FDA, Robert Califf. Let’s get to work on your big idea
Now, more than ever, the U.S. needs scientific leaders who value Americans’ health and safety, who want to improve research and testing,...
-
Senate narrowly confirms Robert Califf to lead the FDA
WASHINGTON – The Senate voted Tuesday 50-46 to officially confirm Robert Califf as the commissioner of the Food and Drug Administration....
-
This family carried a rare mutation that should have been lethal. What was keeping them alive?
The result didn’t make sense. The researcher kept scanning the mouse’s pregnant belly, back and forth, back and forth. They could...
-
The new lightning rod in the fight over high drug prices
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in...
-
Signify Health snaps up a rival in the value-based care battle
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this...
-
STAT+: Pharmalittle: Califf moves closer to becoming FDA commish; U.S. states continue to push for drug-pricing bills
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are enveloping the Pharmalot campus, where the official...
-
STAT+: Pharma companies rarely default on debt, but it remains a risk factor for investors
Pharmaceutical companies may not be known for defaulting on their debt, but a number of drug makers actually did so over the past few years,...
-
Opinion: Creating a digital Hippocratic oath for the 21st century
“First, do no harm.” Those four words, and the Hippocratic oath of which they are a part, have served as an ethical guide for...
-
Opinion: ‘I trust my drug dealer more than I trust this vaccine’
A patient who has taught me a lot about how to best care for people who use drugs floored me one afternoon while she was in the clinic when I...
-
STAT+: Private equity firms are cashing in on the travel nursing business that has boomed during the pandemic
WASHINGTON — As the U.S. health system buckles under the weight of the Covid-19 pandemic, private equity firms are cashing in. Some of...
-
With no votes to spare, Senate advances Califf’s FDA nomination toward final vote
WASHINGTON — In a dramatically close procedural vote Monday night, the Senate voted 49-45 to advance Robert Califf’s nomination to...
-
STAT+: Akili’s paperwork to go public lays bare the challenges ahead for digital therapeutics
Akili Interactive, the maker of a Food and Drug Administration-cleared video game to treat ADHD, has long been bullish on the tremendous...
-
Opinion: Controlled studies ease worries of widespread long Covid in kids
Uncertainty about the effect of Covid-19 on children is gradually being replaced by reassuring news. First, severe complications from Covid-19...
-
STAT+: No more waffling: Belgium discloses penalties for failing to report clinical trial results
In the latest move to crack down on wayward clinical trial sponsors, Belgium may now fine companies, hospitals, and universities that fail to...
-
STAT+: Pharmalittle: FTC may probe PBM contracts with pharmacies; Swiss voters reject animal testing ban
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so...
-
Opinion: Creating a promising pathway for faster access to new drugs — and a Califf confirmation
The FDA’s accelerated approval pathway has a potentially prominent champion — Robert Califf, the scientist President Biden has...
-
Opinion: Immunocompromised people need greater access to monoclonal antibodies
Fleets of delivery trucks leaving warehouses to distribute the first Covid-19 vaccine doses across the country in late December 2020 sent a...
-
STAT+: What we know — and still don’t know — about whether telehealth can cut costs
Telehealth proponents expected the pandemic to net them a windfall of convincing evidence that virtual care could increase quality and cut...
-
Why Covid-19 vaccines are a freaking miracle
Two years into the Covid-19 pandemic, it’s easy to lament all that has come to pass. The devastating losses. The upending of what we...
-
Opinion: ‘Brian’s Song’ at 50 still offers lessons about cancer for today
When “Brian’s Song” made its debut as an ABC Movie of the Week in 1971, this tear-jerker about a professional football...